Raphael Pharmaceutical (RAPH) EPS (Basic) Growth (3y) (2023 - 2024)

Raphael Pharmaceutical (RAPH) EPS (Basic) Growth (3y) (2023 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) Growth (3y) (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	15.17%
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	3.18%
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	2.42%
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	12.25%
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-35.06%
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	13.47%
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	36.60%
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-	27.62%

Download Data